Yanfei Li
Papers
1
Total Citations
9
H-Index
1
About
Yanfei Li is a leading researcher in non-invasive cancer diagnostics, with a primary focus on liquid biopsy technologies for early lung cancer detection. Her most cited work introduces a groundbreaking, cost-effective pfeRNA-based test that distinguishes benign, suspicious, and malignant pulmonary nodules from plasma samples—a critical advancement for reducing unnecessary invasive procedures in patients with early-stage lung cancers. By leveraging plasma protein functional effector small non-coding RNAs (pfeRNAs) as stable biomarkers, Li’s research addresses a major clinical challenge: the accurate classification of indeterminate lung nodules without tissue biopsy. This work, published in 2021, has already garnered 9 citations, reflecting its immediate impact on the field of molecular oncology and precision pulmonology. Li’s contributions are notable for their translational potential, offering a non-invasive, scalable solution that could transform standard-of-care protocols for lung cancer screening and triage. Her innovative approach positions her at the forefront of developing accessible diagnostic tools, with implications for reducing healthcare costs and improving patient outcomes in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1